Who might benefit from immunotherapy? New study suggests possible marker

(Michigan Medicine - University of Michigan) New research finds that PDL-1 expressed in antigen presenting cells -- macrophages and dendritic cells found in the tumor microenvironment and in the nearby lymph nodes -- is a better indicator than PDL-1 in the tumor of who will respond to immunotherapy drugs.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news